You are here

  • Home
  • Online First
  • Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups

Citation Tools

Article menu

other Versions

Download PDFPDF
Original research
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Macchia G, Nardangeli A, Laliscia C, et al
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups
International Journal of Gynecologic Cancer Published Online First: 22 February 2022. doi: 10.1136/ijgc-2021-003237